Clinical Trial Update: A Study of AT-02 in Subjects With Systemic Amyloidosis. [Phase 2]

View source ↗

Summary

AT-02 is being studied in a Phase 2 trial for systemic amyloidosis and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Amyloidosis

Drugs mentioned

• AT-02

Snippet

Sponsor: Attralus, Inc. | Conditions: Amyloidosis; Systemic | Phase 2 | Status: RECRUITING